Executive MBA's (online)
Executive Courses (online)
Programmes for Organisations
Executive MBA's (online)
Programmes for Organisations
Our Cambridge Campus is located in the historic City of Cambridge, with a long tradition of generating academic knowledge. The City's entrepreneurial roots have attracted global pharmaceutical companies and many start-ups.
The current and future investment in Life Sciences in the UK ensures the development of your management skills with partner companies that support the BBI management programmes. Since 2021, Cambridge has become the BBI Life Sciences Campus and will coordinate the online International MBA and Executives Courses in Life Sciences. The on-campus programme for the international MBA in Life Sciences has a first year scheduled for autumn 2023.
This campus elevates the status of the business school as a reference centre for management internationally and the expansion has allowed BBI to meet a wide range of educational needs for scientists during their career development.
Check out the lastest UK Life Sciences industry strategy report. HERE
Catalonia Trade & Investment attracted the highest figure on record in 2021. Read more here
Read our wellcome Board Letter 2021
The objective of the new online course is to accelerate our students career development into higher management positions in the biopharmaceutical industry and across the wider life sciences sector.
The one-year, part-time curriculum will still provide full immersion into drug discovery processes, life science research, medical technologies and healthcare management in Cambridge and worldwide.
The International MBA in Life Sciences is a one-year, full-time executive master’s programme that will be taught in central Cambridge.
The course is designed for scientists who want to develop their careers in applied research and continue their professional development in the biopharmaceutical industry and the wider life sciences sector.
This course has been accredited by BBI Barcelona
Our programmes are directed by our senior level of experiences professionals, lecturers and advisors with a wide experience in the global understanding of the Life Sciences Industry, the pharmaceutical industry, and the biotechnology sector including healthcare, medical devices, and digital health organisations among others.
Our collaborations are oriented to an immediate application of the learning programmes towards international business development centred on the portfolio opportunities and potential products. The result is always a talented team focus and driven to develop the innovation strategy oriented to a global commercialisation to the industry.
The Cambridge phenomenon is best described as an explosion of globally significant companies and innovations across bioscience, medicine and technology over the past 50 years.
Cambridge’s thriving entrepreneurial ecosystem is an ideal location to learn, develop and apply new business skills. Most of the seminars, lectures and interactive tutorials will be held in the bustling City of Cambridge.
The Cambridge course will be taught by a panel of experienced lecturers, who have worked in the Life Sciences industry and have the practical experience of commercialising technology and innovation.
The Cambridge team will also draw on Barcelona lecturers for some of the teaching, especially in drug discovery, but will teach a broader remit across the whole Life Sciences sector. The Cambridge Campus will have its own wellbeing officer to support students' needs during their course. The Cambridge course has been accredited by BBI Barcelona and is managed by the Cambridge Office.
Key international partners, such governmental organisations, bioindustry associations and trade bodies, enable the BBI to extend its global reach from Barcelona, Cambridge, Mexico and beyond.
The BBI has entered into a Strategic Partnership as Innovation Advisors to the Anglo Nordic Life Sciences Conference
The Biotechnology Business Institute (BBI) has been invited to join the board committee of the Anglo Nordic Life Sciences Conference. The BBI will act as innovation advisors by enabling investments in early-stage companies and helping with cluster development through international networking with key decision makers.
The Anglonordic Conference is mostly for European investors to meet with R&D companies from the Nordic countries and the UK. The Conference provides an innovative forum for investors and companies to connect with each other through an established format of panel discussions, parallel technology and biotech investment rooms, as well as opportunities for 1:1 meetings. The BBI believes that this 19th Conference in London will provide exceptional value for money for the companies that are planning to attend.
BBI Cambridge Limited has successfully attained the Biotechnology Business Institute’s accreditation for the MBA courses to be delivered in Cambridge. Following the BBI Board’s formal approval under the standards of international full-time educational courses.
BBI Cambridge Ltd has been certified by the Information Commissioner's Office (ICO). The ICO is the UK’s independent authority set up to uphold information rights in the public interest and data privacy for individuals. The relevant certificate can be found here.
The objective of the ISO International Standards for a Quality Management System is to help organizations be effective and strategic while being able to adapt to the constantly changing market dynamics. It also suggests various forms of correction and improvement such as breakthrough change, innovation and re-organization.
The ISO 9001:2015 is the latest edition of the ISO 9001, the only certifiable body of the ISO 9000 family regarding Quality Management Systems. It is the most widely known among the International Standards with regard to quality control and quality assurance for organizations of any type and size. Its main principles for quality management include: Customer Focus, Leadership, People Engagement, Process approach, Improvement, Evidence-based decision making, Relationship Management.
Here are some of the most frequent questions from our candidates
The Biotechnology Business Institute (BBI) is an international business school focused on training a new generation of scientific managers and executives to prepare for their future careers. The BBI facilitates early-stage business development activities in partnership with the many stakeholders in the biotechnology sector and the pharmaceutical industry worldwide. A core focus is on new drug development to treat unmet medical need but also with broadening interests across the Life Sciences sector.
The Biotechnology Business Institute was founded to develop the next generation of talent in the international Life Sciences sector for scientists seeking to advance their careers in the pharmaceutical and biotechnology industries. We are committed to becoming a leading international academic institution in the management of Life Sciences, through enabling the career development of a new wave of global business leaders driving disruptive change throughout the ecosystem.
Our complementary MBA programmes in Biotechnology and in Life Sciences enable scientists to enter this growing industrial sector each year. We help our students develop a clear vision of their career progression into future leadership roles. By using the new skills and practical experiences from our courses, our alumni go on to join the some of the most notable institutions, companies and national healthcare systems with international reputations.
With a presence in two of the main innovation centres in Europe, Barcelona, and Cambridge, and the second largest market in the pharmaceutical industry in Latin America our students can choose which campus will best meet their needs.
As the International BBI headquarters, the Barcelona Campus is focused on drug discovery, built on a track record since 2013 delivering management programmes for scientists wanting to develop their careers in the global pharma & biotechnology industry.
The European headquarters, our Cambridge Campus, has a broader remit across the entire Life Science sector. At Cambridge, UK, our students can realise their objective of establishing a global network of contacts in the broader spectrum of commercial opportunities in Life Sciences.
Know more about our campuses
Every day is different throughout the year. During the first stage, when students take their common modules, apart from the evening classes from Monday to Thursday, the students also develop their career impact programmes. These programmes have their project meetings at various research centres and participate in extra-curriculum activities.
For the final semester in Barcelona, each student develops their own academic internship programme depending on their chosen career itinerary chosen. All programmes have the same number of assignments and group work to complete. Typically, the second semester is focused increasing the time spent on students’ career-related activities.
The BBI network is formed by our alumni, the academic staff, lecturers, partner companies and the technology transfer offices who collaborate with us. Over the years, we have developed a community over 700 people globally in direct contact every year.
For more information, visit our BBI community Report